Regulators shot down treatments for multiple sclerosis and premature labor, and medicines for stroke and diabetes fizzled in large-scale trials.

FORBES: J&J An unfinished symphony

They note that it hits only one unproven mechanism behind stroke and that it may be necessary to hit multiple biological pathways to get a significant effect.

FORBES: Brain Repair